Jeena Sikho Lifecare Limited · NSE:JSLL
Jeena Sikho Lifecare — Investor Presentation (May 2024)
40 slides from Jeena Sikho Lifecare's investor presentation, May 16, 2024
Slide 1: Cover letter to NSE: Investor Presentation
To, The Manager, Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai-400051 NSE Symbol: JSLL ISIN: INE0J5801011 Dear Sir/Ma’am, Sub: Investor Presentation Please find enclosed herewith the Investor Presentation of the Com
Slide 2: Jeena Sikho Lifecare Limited Investor Presentation FY24
Jeena Sikho Lifecare Limited NSE: JSLL | Bloomberg: JSLL:IN Investor Presentation FY24 | May 2024
Slide 3: Inside this Presentation
Inside this Presentation 01 02 Introduction Unique Business to JSLL Model Positioning 03 04 Breadth of Way Operations Forward 05 06 Annual Financial Quarterly Performance Highlights Highlights
Slide 4: Introduction to Jeena Sikho Lifecare
Introduction to Jeena Sikho Lifecare Jeena Sikho Lifecare Limited
Slide 5: About the Company: Problem and Solution
ABOUT THE COMPANY Problem: Modern health care services & allopathy medicine is often expensive, unavailable at non-urban locales, and fails to fully address a slew of lifestyle health care ailments. Solution: India’s premier ayurveda health care and medicine enterprise, offering quality, affordable
Slide 6: Introduction to Jeena Sikho Lifecare
ABOUT THE COMPANY Introduction to Jeena Sikho Lifecare Operational Operational Beds Beds in Cities & towns States hospitals clinics & operational pipeline covered covered day care SKUs in Ayurveda medicine ROCE* - Capital-light 3Y Top line CAGR^ - One Listed on NSE & product portfolio business model
Slide 7: Journey so far
ABOUT THE COMPANY Journey so far Idea Products/medicines Health care services Raised growth capital born business commenced commenced to expand in both 2009 2009 2013 2022 The idea of Commenced ayurveda Established first ayurveda health Successfully raised ₹55.5 Cr from IPO Jeena Sikho medicine sale
Slide 8: Leadership at Jeena Sikho
ABOUT THE COMPANY Leadership at Mr. Nanak Chand Mr. Gaurav Mohan Garg Jeena Sikho Chief Financial Officer Business Development Head Mr. Sahil Jain Dr. Nidhi Punia Operations Head Doctor Mr. Manish Grover Mrs. Bhavna Grover Managing Director Whole Time Director Dr. Raghuvendra Mr. Kapil Dev Doctor Bu
Slide 9: About the founder
ABOUT THE COMPANY About the founder Expertise and Contributions With over two decades of experience, Acharya Manish Ji possesses deep domain expertise in Ayurvedic medicines and treatments. He is an ingenious practitioner of Ayurvedic medicine, drawing from his own experiences, profound wisdom, inte
Slide 10: Superior Business Model Positioning
Superior Business Model Positioning Jeena Sikho Lifecare Limited
Slide 11: Superior business model positioning
SUPERI OR BUSI NESS MODEL POSI TI ONI NG Superior business model positioning A unique combination of product & service revenue stream Ayurveda health Ayurveda health Monumental synergies care services care products between the two verticals • Operated out of hospitals & • Sales generation out of Sig
Slide 12: JSLL's Business Structure
SUPERI OR BUSI NESS MODEL POSI TI ONI NG JSLL’s Business Structure JSLL’s Business Unique business Verticals model 1. To benefit from significant operating Services Products leverage of services vertical 2. Well-supported by B2C: Tele-calling healthy cash-generation & e-com from high-margin Hospital
Slide 13: JSLL's unique capital-light approach
SUPERI OR BUSI NESS MODEL POSI TI ONI NG JSLL’s unique capital-light approach Low CAPEX Mix of own & Unique hub-and- Capital-light per bed franchise assets spoke model business model • Setup cost of ~₹2.5-3.5 • 53/111 facilities are under • Clinics & day-care Resulting in: lakh per bed (a typical fr
Slide 14: JSLL's flywheel effect
SUPERI OR BUSI NESS MODEL POSI TI ONI NG JSLL’s flywheel Quality services, effective treatment, creating happy effect customers Satisfied patients in- Happy Customers More facilities, better turn create best doctors, and higher word-of-mouth operating efficiencies marketing Higher Growth Better ROCE
Slide 15: Robust sales funnel
SUPERI OR BUSI NESS MODEL POSI TI ONI NG Robust sales funnel Social Media Channels: youtube.com/@Chikitsaguru (760K subscribers - 2.5K videos) youtube.com/@haveshuddhi (339K subscribers - 1.6K videos) 17 Cumulative OPD, COD & VC customers served: All resulting in growing IPD volumes: 72-hour health
Slide 16: Attractive unit economics
SUPERI OR BUSI NESS MODEL POSI TI ONI NG Attractive unit economics Revenue potential Typical CAPEX of a OPEX of a 100-bed Swift paybacks 100-bed facility facility (monthly) Superior ROCEs (%) ₹7,900/day/bed Bundled service + product Leased facility Fixed Costs revenue potential per day 12-18 months
Slide 17: Key pillars of business model
SUPERI OR BUSI NESS MODEL POSI TI ONI NG Key pillars of business model INSURANCE & GOVERNMENT PANEL DOCTORS & MEDICAL STAFF Insurance Empanelment’s Government Panel • Delhi – CGHS, CAPF, DGEHS, DDA, DJB, CBSE, CWC, CSIR ~307 ~483 • Rajasthan – CGHS, RGHS Certified ayurveda doctors Supporting health
Slide 18: Positioned for leadership
SUPERI OR BUSI NESS MODEL POSI TI ONI NG Positioned for leadership Market Humongous size of Corporate leadership opportunity governance • ~12% share of Jeena Sikho in • India has an estimated ~1.9 1. Maiden dividend payout in NABH Accredited Panchakarma million hospital beds as per 2024 post listing
Slide 19: Breadth of Operations
Breadth of Operations Jeena Sikho Lifecare Limited
Slide 20: Hub-and-spoke geographical expansion
BREADTH OF OPERATI ONS Hub-and-spoke Assam 1 clinic Bihar 1 hospital | 10 clinics Chandigarh 1 hospital geographical Chhattisgarh 2 clinics Delhi 3 hospital | 8 clinics Goa 1 hospital expansion Gujarat 2 hospital | 4 clinics Haryana 3 hospital | 7 clinics Himachal Pradesh 4 clinics Jammu 1 clinic 32
Slide 21: Key health care facilities
BREADTH OF OPERATI ONS Key health care facilities Meerut, Lucknow, Derabassi, Navi Mumbai, Uttar Pradesh Uttar Pradesh Chandigarh Maharashtra Since Since Since Since Dec-2022 Jun-2022 Oct-2020 Nov-2022 304 75 114 150 Beds Beds Beds Beds NABH NABH NABH NABH Accredited Accredited Accredited Accredited
Slide 22: Health Care Camps
BREADTH OF OPERATI ONS Health Navi Mumbai Camp • Dates: 1st to 3rd March Meerut Camp • Dates: 29th to 31st March Care Camps • State name: Maharashtra • State name: Uttar Pradesh • Duration: 3 days • Duration: 3 days 60 118 Case Studies VISITORS ATTENDED VISITORS ATTENDED ~₹30 lakhs ~₹59 lakhs DIRECT
Slide 23: Comprehensive healthcare services – 1/2
BREADTH OF OPERATI ONS Comprehensive healthcare services – 1/2 Health Care Key Natural Services Offered Diseases Reversals IN-PATIENT OUT-PATIENT 72-HOUR KIDNEY LIVER DETOX CANCER ARTHRITIC NEUROLOGICAL DEPARTMENT DEPARTMENT HEALTH FAILURE AND REVERSAL PROGRESSION DISORDER DISORDERS (IPD) THROUGH (O
Slide 24: Comprehensive healthcare services – 2/2
BREADTH OF OPERATI ONS Comprehensive healthcare services – 2/2 Ailments Treated THYROID OBESITY CHOLESTEROL MIGRAINE DEPRESSION JOINT PAIN BACK PAIN EYE ACIDITY & & WEIGHT TREATMENT GAS LOSS ANXIETY PSORIASIS ULCER SEXUALLY FISSURE SKINCARE LEUKODERMA ASTHMA TRANSMITTED DISEASES 23 Jeena Sikho Lifec
Slide 25: Ayurveda product portfolio
BREADTH OF OPERATI ONS Ayurveda product portfolio Our Top Selling Existing sales Products channels 1. Call centres & e-com 2. At health care centres Plans to tap OTC sales channel at pharmacies beginning H2FY25 ~300 SKUs in portfolio ~90% Overall Gross Margins in product 24 Jeena Sikho Lifecare Limi
Slide 26: Call centre operations
BREADTH OF OPERATI ONS Call centre operations Dedicated health care call centre for proactive sales Video-call Consultations & customer support operations: (#) 53,292 Driving customer order Facilitating sales leads placement & processing for for health care centres medicine portfolio 11,959 FY23 FY2
Slide 27: Customer Testimonials
BREADTH OF OPERATI ONS Customer Testimonials Comedian Mr. Rajesh Prime Minister Mr. Vivek Smt. Neeta Bharti Singh’s Narang, Narendra Kumar Kapoor’s Mother Derabassi Modi’s Brother Chandigarh Testimony When Mrs. Singh was admitted He was suffering from Crohn's When Modi ji's brother came to A Liver C
Slide 28: Way Forward
Way Forward Jeena Sikho Lifecare Limited
Slide 29: Outlook
WAY FORWARD Outlook 01 Improve utilization rates of existing 02 Launch new centres & bed addition in 03 Tap OTC sales channel for assets existing centres medicine sales 04 Expand portfolio: launch new product 05 Enablement of cashless 06 Expected increase in coverage under kits insurance to aid Gove
Slide 30: Annual Financial Highlights
Annual Financial Highlights Jeena Sikho Lifecare Limited
Slide 31: Key Operating Metrics
ANNUAL FI NANCI AL HI GHLI GHTS Key Operating Metrics Operational Beds & Occupancy Avg. Revenue Per Bed IPD Patient Volumes OPD Patient Volumes (#) (In ₹) (#) (# Lakh) 1 ,4 0 0 1,277 13,159 2.52 1 ,2 0 0 7,900 1 ,0 0 6,100 8 0 1.57 6 0 460 490 5,728 1.08 4 0 280 2 0 1,418 0 FY23 FY24 FY23 FY24 FY22
Slide 32: Key Performance Indicators
ANNUAL FI NANCI AL HI GHLI GHTS Key Performance Indicators Revenue from Operations EBITDA & EBITDA Margin (In ₹ Crore) (In ₹ Crore & %) 1 0 29% 3 5 % 324 9 0 3 0 % 8 0 23% 93 2 5 % 7 0 204 6 0 2 0 % 146 5 0 12% 12% 136 4 0 46 1 5 % 3 0 1 0 % 2 0 17 18 5 % 1 0 0 0 % FY21 FY22 FY23 FY24 FY21 FY22 FY23
Slide 33: 4Y Income Statement
ANNUAL FI NANCI AL HI GHLI GHTS 4Y Income Statement (In ₹ Lakhs) PARTICULARS FY21 FY22 FY23 FY24 REVENUE FROM OPERATIONS 13,581 14,645 20,390 32,441 GROSS PROFIT 11,884 12,971 18,193 29,298 GROSS PROFIT MARGIN (%) 88% 89% 89% 90% OPERATING EXPENSES 10,196 11,159 13,586 19,999 EBITDA 1,688 1,812 4,60
Slide 34: 4Y Balance Sheet
ANNUAL FI NANCI AL HI GHLI GHTS 4Y Balance Sheet (In ₹ Lakhs) PARTICULARS FY21 FY22 FY23 FY24 TOTAL EQUITY 2,395 3,656 12,580 19,225 NON-CURRENT LIABILITIES 92 117 63 88 BORROWINGS 15 81 54 32 CURRENT LIABILITIES 2,428 2,383 2,460 2,741 BORROWINGS 1,188 663 27 22 TRADE PAYABLES 328 463 607 446 TOTAL
Slide 35: 4Y Cash Flow Statement
ANNUAL FI NANCI AL HI GHLI GHTS 4Y Cash Flow Statement (In ₹ Lakhs) PARTICULARS FY21 FY22 FY23 FY24 CASH FROM OPERATING ACTIVITIES 1752.76 1747.95 1716.94 3676.74 CASH FROM INVESTING ACTIVITIES (858.90) (1963.76) (5723.16) (1812.43) CASH FROM FINANCING ACTIVITIES (153.22) (451.08) 4800.34 (344.40) N
Slide 36: Quarterly Performance Highlights
Quarterly Performance Highlights Jeena Sikho Lifecare Limited
Slide 37: H2 & FY24 Income Statement
QUARTERLY PERFORMANCE HI GHLI GHTS H2 & FY24 Income Statement (In ₹ Lakhs) YOY YOY PARTICULARS H2FY23 H1FY24 H2FY24 FY23 FY24 CHANGE (%) CHANGE (%) REVENUE FROM OPERATIONS 11,739 15,736 16,705 42% 20,390 32,441 59% GROSS PROFIT 10,555 14,197 15,101 43% 18,193 29,298 61% GROSS PROFIT MARGIN (%) 90% 9
Slide 38: Management Commentary
QUARTERLY PERFORMANCE HI GHLI GHTS Management Commentary Acharya Manish Ji MANAGING DIRECTOR “I am delighted to share with you the robust financial & As we look ahead, our focus will be on improving occupancy rates operational performance of Jeena Sikho Lifecare for both H2 and in our existing asset
Slide 39: Market Statistics
QUARTERLY PERFORMANCE HI GHLI GHTS Market Statistics 31.83% PUBLIC 67.91% PROMOTERS NSE Symbol JSLL Listing Date April 19, 2022 IPO Issue Price ₹150 Current Market Price ₹1,175 52 Week High/Low ₹175 / ₹1,175 Shares Outstanding 2.49 Cr Market Capitalization ₹2,921 Cr Industry Classification Healthcar
Slide 40: Contact Us
Contact Us Contact Details Nanak Chand This document which have been prepared by Jeena Sikho Lifecare Limited (the “Company” or ”JSLL”), have been prepared Chief Financial Officer solely for information purposes. This document has been prepared by the Company based on information and data which the
Jeena Sikho Lifecare — Investor Presentation (May 2024) on 6ix